Fig. 6
From: Mitophagy related gene signature for prognosis and therapeutic evaluation in KIRC
Analysis of the association between the prognostic signature and the tumor microenvironment in KIRC. (A) Evaluation of immune cell infiltration in TCGA-KIRC patients using multiple computational approaches. (B) Relevance between immune-related subtypes and risk classification based on the prognostic model. (C) Comparative analysis of immune cell abundance between high-risk and low-risk groups. (D) Functional differences in immune activities across the two risk groups. (E) Assessment of immune checkpoint expression in relation to risk stratification. (F) Association between risk scores and tumor immune dysfunction and exclusion (TIDE) metrics. Statistical significance denoted as *p < 0.05, **p < 0.01, ***p < 0.001.
